J.P. Marvel Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-94,753
| Closed | -$2.3M | – | 66 |
|
|
2025
Q2 | $2.3M | Sell |
94,753
-2,544
| -3% | -$59.3K | 0.37% | 42 |
|
|
2025
Q1 | $2.47M | Sell |
97,297
-3,731
| -4% | -$97.6K | 0.43% | 43 |
|
|
2024
Q4 | $2.68M | Sell |
101,028
-44,840
| -31% | -$1.22M | 0.44% | 41 |
|
|
2024
Q3 | $4.22M | Sell |
145,868
-590
| -0.4% | -$17.2K | 0.69% | 39 |
|
|
2024
Q2 | $4.1M | Sell |
146,458
-1,791
| -1% | -$49.3K | 0.67% | 39 |
|
|
2024
Q1 | $4.11M | Sell |
148,249
-8,455
| -5% | -$235K | 0.71% | 41 |
|
|
2023
Q4 | $4.51M | Sell |
156,704
-55,340
| -26% | -$1.67M | 0.89% | 32 |
|
|
2023
Q3 | $7.03M | Sell |
212,044
-1,315
| -0.6% | -$46.5K | 1.51% | 23 |
|
|
2023
Q2 | $7.83M | Sell |
213,359
-7,889
| -4% | -$307K | 1.63% | 22 |
|
|
2023
Q1 | $9.03M | Sell |
221,248
-219
| -0.1% | -$9.46K | 2.04% | 17 |
|
|
2022
Q4 | $11.3M | Sell |
221,467
-303
| -0.1% | -$14.5K | 2.66% | 13 |
|
|
2022
Q3 | $9.71M | Hold |
221,770
| – | – | 2.47% | 15 |
|
|
2022
Q2 | $11.6M | Hold |
221,770
| – | – | 2.8% | 13 |
|
|
2022
Q1 | $11.5M | Buy |
221,770
+355
| +0.2% | +$18.4K | 2.34% | 17 |
|
|
2021
Q4 | $13.1M | Buy |
221,415
+15,521
| +8% | +$769K | 2.56% | 12 |
|
|
2021
Q3 | $8.86M | Buy |
205,894
+5,084
| +3% | +$225K | 2.67% | 16 |
|
|
2021
Q2 | $7.86M | Hold |
200,810
| – | – | 1.67% | 24 |
|
|
2021
Q1 | $7.28M | Sell |
200,810
-110
| -0.1% | -$3.91K | 1.72% | 24 |
|
|
2020
Q4 | $7.4M | Sell |
200,920
-10,990
| -5% | -$403K | 1.91% | 22 |
|
|
2020
Q3 | $7.38M | Sell |
211,910
-516
| -0.2% | -$18.1K | 2.12% | 17 |
|
|
2020
Q2 | $6.59M | Sell |
212,426
-55,286
| -21% | -$1.88M | 2.08% | 19 |
|
|
2020
Q1 | $8.29M | Sell |
267,712
-474
| -0.2% | -$16.2K | 3.14% | 11 |
|
|
2019
Q4 | $9.97M | Sell |
268,186
-11
| -0% | -$392 | 2.88% | 13 |
|
|
2019
Q3 | $9.14M | Buy |
+268,197
| New | +$9.75M | 2.93% | 9 |
|
|
2019
Q1 | $10.9M | Sell |
269,372
-622
| -0.2% | -$24.9K | 3.52% | 6 |
|
|
2018
Q4 | $11.2M | Buy |
+269,994
| New | +$11.2M | 4.03% | 3 |
|
|
2018
Q2 | $9.34M | Sell |
271,261
-2,683
| -1% | -$91.7K | 2.86% | 10 |
|
|
2018
Q1 | $9.22M | Sell |
273,944
-285
| -0.1% | -$9.8K | 2.85% | 11 |
|
|
2017
Q4 | $9.42M | Buy |
274,229
+6,320
| +2% | +$215K | 2.87% | 8 |
|
|
2017
Q3 | $9.07M | Buy |
267,909
+4,014
| +2% | +$129K | 2.89% | 9 |
|
|
2017
Q2 | $8.41M | Sell |
263,895
-4,332
| -2% | -$137K | 2.78% | 8 |
|
|
2017
Q1 | $8.71M | Sell |
268,227
-5,016
| -2% | -$158K | 2.88% | 7 |
|
|
2016
Q4 | $8.42M | Sell |
273,243
-2,572
| -0.9% | -$78.5K | 2.88% | 10 |
|
|
2016
Q3 | $8.86M | Sell |
275,815
-12,110
| -4% | -$405K | 3.14% | 5 |
|
|
2016
Q2 | $9.62M | Sell |
287,925
-4,451
| -2% | -$142K | 3.37% | 6 |
|
|
2016
Q1 | $8.22M | Sell |
292,376
-468
| -0.2% | -$13.4K | 2.96% | 8 |
|
|
2015
Q4 | $8.97M | Buy |
+292,844
| New | +$9.21M | 3.12% | 7 |
|
|
2015
Q2 | $9.16M | Sell |
287,996
-791
| -0.3% | -$25.8K | 3.08% | 7 |
|
|
2015
Q1 | $9.53M | Hold |
288,787
| – | – | 3.25% | 7 |
|
|
2014
Q4 | $8.54M | Sell |
288,787
-252
| -0.1% | -$7.23K | 2.97% | 10 |
|
|
2014
Q3 | $8.11M | Sell |
289,039
-1,902
| -0.7% | -$53.4K | 2.93% | 9 |
|
|
2014
Q2 | $8.19M | Sell |
290,941
-991
| -0.3% | -$28.2K | 2.79% | 11 |
|
|
2014
Q1 | $8.9M | Buy |
291,932
+8,443
| +3% | +$252K | 3.13% | 5 |
|
|
2013
Q4 | $8.24M | Buy |
283,489
+190
| +0.1% | +$5.53K | 2.95% | 8 |
|
|
2013
Q3 | $7.72M | Sell |
283,299
-264
| -0.1% | -$7.18K | 2.99% | 7 |
|
|
2013
Q2 | $7.54M | Buy |
+283,563
| New | +$7.83M | 3.14% | 7 |
|
Other funds holding PFE
J.P. Marvel Investment Advisors's PFE Position: Q3 2025 in Review
J.P. Marvel Investment Advisors sold out of Pfizer (PFE) in Q3 2025, closing a stake of 94,753 shares — an estimated $2.3M sold.
J.P. Marvel Investment Advisors first reported a position in PFE in Q2 2013 and held it in 46 quarters. The position peaked at $13.1M in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- J.P. Marvel Investment Advisors reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- J.P. Marvel Investment Advisors sold 94,753 Pfizer shares in Q3 2025, an estimated $2.3M.
- J.P. Marvel Investment Advisors first reported a position in Pfizer in Q2 2013 and held it in 46 quarters.
- J.P. Marvel Investment Advisors's Pfizer position peaked at $13.1M in Q4 2021.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on J.P. Marvel Investment Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.